Hospital Universitario General De Villalba

At Hospital Universitario General De Villalba, the Psychiatry program is centered on mental disorders such as schizophrenia, treatment-resistant depression, and Major Depressive Disorder with Insomnia Symptoms. The trials are mainly designed to test new treatments, understand symptom improvement, and evaluate longer-term safety and effectiveness.

• Research on schizophrenia focuses on negative symptoms and cognitive impairment, with studies also collecting additional safety information.
• Depression studies examine new approaches for treatment-resistant depression and depressive symptoms linked to insomnia.
• Several trials aim to assess whether investigational therapies can improve daily functioning and maintain benefit over time.

This area reflects a strong commitment to improving care for people with complex and hard-to-treat psychiatric conditions.

The site is also active in nervous system diseases, with a clear focus on Tourette’s Disorder in children, adolescents, and adults. These studies are intended to evaluate symptom control, long-term tolerability, and whether treatment benefits can be maintained.

• Trials assess the ongoing safety and tolerability of a new therapy for Tourette’s Disorder.
• Research also looks at maintaining treatment effect in younger patients living with chronic tic symptoms.
• The overall goal is to support better management of a condition that can affect school, work, and social life.

The Hospital Universitario General De Villalba contributes to research aimed at improving both symptom relief and everyday quality of life for people with tic disorders.

Another major research focus covers respiratory tract diseases and immune system diseases, especially allergic rhinitis, rhinoconjunctivitis, and associated asthma. These trials are exploring whether new allergy treatments can reduce symptoms during pollen seasons and improve control in people with seasonal allergies.

• Studies evaluate immunotherapy for grass and olive pollen allergies in patients with nasal and eye symptoms.
• Research includes comparisons against placebo to measure symptom relief and reduced medication use.
• Some trials also assess changes in allergen sensitivity to better understand treatment impact.

This work highlights the site’s interest in testing therapies that may offer longer-lasting relief for common allergic diseases.

Within nutritional and metabolic diseases, the site is involved in research on lactose intolerance and the diagnosis of hypolactasia in children. The main purpose is to improve how this condition is identified in routine care and to support more accurate diagnosis for symptomatic patients.

• Trials examine diagnostic tools for children with symptoms suggestive of lactose intolerance.
• Research aims to confirm whether a proposed test threshold can reliably distinguish affected from unaffected patients.
• The focus is on making diagnosis more practical and clinically useful.

These studies add a diagnostic dimension to the broader clinical research portfolio at Hospital Universitario General De Villalba.

The site also participates in research on female urogenital diseases, particularly stress or mixed urinary incontinence in women over 50 who have not responded well to standard treatment. The trials are designed to explore new options for improving bladder control and daily comfort.

• Studies focus on women with persistent urinary leakage despite conventional care.
• Research is aimed at assessing the feasibility and safety of a potential regenerative approach.
• The goal is to find better ways to support patients with a condition that can strongly affect quality of life.

This field shows the site’s broader interest in practical, patient-centered research across multiple specialties.